OneMedNet Corporation reported that its stockholders approved an amendment and restatement of the company's 2022 Equity Incentive Plan during the 2026 Annual Meeting of Stockholders, held virtually on September 18, 2026. The meeting was conducted via a live audio webcast.
Under the approved amendment, the number of authorized shares under the 2022 Plan was increased by 1,000,000 shares. The plan became effective immediately upon stockholder approval. A summary of the plan's material terms is included in the company's definitive proxy statement filed with the SEC on August 19, 2026. The full text of the plan is filed as Exhibit 10.1 to this report.
The Annual Meeting also addressed several other proposals. Stockholders elected three Class III directors to the Board of Directors to serve three-year terms expiring at the 2029 Annual Meeting. The nominees were Dr. Kenneth Alleyne, Sherry Coonse McCraw, and Dr. Jeffrey Yu.
Additionally, stockholders ratified the appointment of WithumSmith+Brown, PC as the company's independent registered public accounting firm for the year ending December 31, 2026. The meeting also included a proposal to approve an amendment to the company's certificate of incorporation to effect a reverse stock split of the common stock. The split ratio was proposed to be determined by the Board of Directors, ranging from a 1-for-5 to a 1-for-20 ratio.
Quorum was established with 41,841,452 votes represented, accounting for 70.57% of the votes entitled to be cast.
